SBILIFE Share Price Target 2035

CAGR-based price projection for SBI Life Insurance Company Limited (SBILIFE) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (-4.2% CAGR)
Rs 1,171
2035 Target
Base Case (-10.5% CAGR)
Rs 635
2035 Target
Bull Case (-15.7% CAGR)
Rs 369
2035 Target

Current Market Snapshot

CMP: Rs 1,721.60
52W High: Rs 1,982.50
52W Low: Rs 1,654.10
1Y CAGR: -19.9%
3Y CAGR: -10.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,649 Rs 1,541 Rs 1,451
2028 Rs 1,580 Rs 1,380 Rs 1,223
2029 Rs 1,514 Rs 1,235 Rs 1,030
2030 Rs 1,451 Rs 1,106 Rs 868
2031 Rs 1,390 Rs 990 Rs 732
2032 Rs 1,331 Rs 886 Rs 617
2033 Rs 1,276 Rs 793 Rs 520
2034 Rs 1,222 Rs 710 Rs 438
2035 Rs 1,171 Rs 635 Rs 369

Other SBILIFE Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the SBILIFE share price target for 2035?

Based on historical growth analysis, the SBILIFE share price target for 2035 ranges from Rs 1,171 (conservative) to Rs 635 (base case) to Rs 369 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of SBILIFE?

The current market price of SBILIFE (SBI Life Insurance Company Limited) is Rs 1,721.60. The 52-week high is Rs 1,982.50 and 52-week low is Rs 1,654.10.

Is SBILIFE a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for SBILIFE price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -4.2% CAGR), Base (-10.5% CAGR), and Bull (optimistic at -15.7% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.